Mergers, Acquisitions & Divestitures

Ensure Maximum Deal Value & Streamlined Operations

In today’s M&A-heavy life sciences climate, the role that IT plays in integration and divestiture planning in both the short- and long-term success of a deal cannot be overstated.

From helping small firms audit their systems in advance of activity to assisting Tier 1 clients in crafting and executing upon their post-transaction integration strategy, our team has rich experience across the entire deal spectrum.

Results-Focused M&A IT Consulting

Technology plays a role in every aspect of the life sciences M&A process, starting long before a deal is finalized. Unlocking maximum deal value requires an experienced hand who can advise on strategy, best practices and feasibility, and execute like a member of the team. No matter our clients’ role in the transaction, our goal is simple: Optimize IT systems and processes to deliver maximum financial and operational returns.

Mergers, Acquisitions & Divestitures Services

Daelight has helped pharmaceutical, biotech and medical device firms of all sizes:

  • Swiftly understand opportunities and risks during due diligence
  • Ready themselves for acquisition by assessing and shoring up technology systems
  • Effectively and efficiently integrate systems in a compliant manner post-transaction
  • Carve out business lines or units for divestiture

Our M&A playbook is unique among life sciences IT consultants. We offer end-to-end service for any party, from initial planning and conceptualization through project management and execution. Our clients get highly experienced consultants from Day 1 through project completion; there’s no “bait and switch” via subcontracting or assigning unvetted resources. Regardless of the project size or scope, we’re there as part of the team until the results show.